Jhpiego will offer hands-on demonstrations of the single visit approach (SVA) to cervical cancer prevention during the 8th Stop Cervical, Breast and Prostate Cancer in Africa Conference to be held July 20–22 at the Safari Hotel Conference Centre in Windhoek, Namibia. The conference will highlight universal access to cervical cancer prevention.
Jhpiego, working with stakeholders and partners, pioneered the single visit approach (SVA) in 1995, a practical, clinically safe, acceptable and effective approach to cervical cancer prevention for low-resource settings. Since then, Jhpiego has implemented cervical cancer prevention activities in 14 countries, adapting programs to meet each setting’s unique needs, goals and resources. The SVA consists of visual inspection of the cervix using vinegar or dilute acetic acid (VIA) to detect cervical precancerous lesions, followed by the offer of treatment using a freezing technique (cryotherapy), in the same visit. The method is so cost effective, that approximately 50 women can be screened using VIA for the cost of one traditional Pap smear.Jhpiego is currently developing a practical and inexpensive way of providing cryotherapy, called CryoPop (an innovation under development). The World Health Organization considers pairing screening and treatment of the cervix as one of the “best buys” for addressing non-communicable diseases.